Word limits best explain failings of industry supported meta-analyses
- PMID: 17095791
- PMCID: PMC1635572
- DOI: 10.1136/bmj.39024.372662.1F
Word limits best explain failings of industry supported meta-analyses
Conflict of interest statement
Competing interests: JJD has contributed to the Cochrane Collaboration for over a decade, is currently a member of the steering group of the Cochrane Collaboration and Treasurer. He has co-authored 14 Cochrane reviews, and is the lead editor of the statistical section of the
Comment in
-
Authors' reply on Cochrane reviews v industry supported meta-analyses.BMJ. 2006 Nov 18;333(7577):1072-3. doi: 10.1136/bmj.39030.732917.3a. BMJ. 2006. PMID: 17120335 Free PMC article. No abstract available.
Comment on
-
Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review.BMJ. 2006 Oct 14;333(7572):782. doi: 10.1136/bmj.38973.444699.0B. Epub 2006 Oct 6. BMJ. 2006. PMID: 17028106 Free PMC article.
References
-
- Garner SE, Fidan DD, Frankish RR, Judd MG, Shea BJ, Towheed TE, et al. Celecoxib for rheumatoid arthritis. Cochrane Database Syst Rev 2002;4:CD003831. - PubMed
-
- Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. celecoxib long-term arthritis safety study. JAMA 2000;284:1247-55. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources